Rad51 has not been identified as an XPO1 cargo molecule, but prior work in acute myeloid leukemia has demonstrated that XPO1 inhibition via selinexor is able to decrease the transcription of Rad51 mRNA transcription resulting in lower levels of protein expression, thus presenting a potential explanation for this observation [49]. Here, RAD51 is linked to acute myeloid leukemia.